# L1CAM

## Overview
L1CAM, or L1 cell adhesion molecule, is a gene that encodes a transmembrane glycoprotein crucial for neural development. The protein product of L1CAM is involved in various cellular processes, including neuronal migration, axon guidance, and synaptic plasticity, by facilitating cell-cell adhesion and intracellular signaling. Structurally, the L1 cell adhesion molecule is characterized by six immunoglobulin-like domains and five fibronectin type III domains, which enable it to engage in homophilic and heterophilic interactions essential for its function (Grumet2003The; Hlavin1991Molecular). L1CAM's role extends beyond neural development, as mutations in the gene are linked to several X-linked neurological disorders, collectively known as L1 syndrome, and its altered expression is associated with cancer progression (Fransen1998Genotypephenotype; Schäfer2010L1CAM).

## Structure
L1CAM (L1 cell adhesion molecule) is a transmembrane glycoprotein that plays a crucial role in neural development. Its primary structure consists of a sequence of amino acids forming six immunoglobulin-like domains (Ig1-Ig6) and five fibronectin type III domains (Fn1-Fn5) (Grumet2003The; Hlavin1991Molecular). The Ig domains are involved in homophilic and heterophilic interactions, with Ig1-Ig4 forming a horseshoe-shaped conformation critical for binding (Grumet2003The). The secondary structure includes beta-sheets and loops, typical of immunoglobulin and fibronectin domains (Hlavin1991Molecular).

The tertiary structure of L1CAM involves the folding of these domains into a dynamic equilibrium between folded and extended conformations, which is essential for its binding activities (Grumet2003The). The quaternary structure may involve homophilic interactions, particularly through the horseshoe conformation of Ig1-Ig4 (Grumet2003The).

L1CAM undergoes post-translational modifications, including extensive Asn-linked glycosylation, which accounts for 25% of its mass, and proteolytic cleavage at specific sites (Grumet2003The). Splice variants of L1CAM result in different isoforms, affecting its conformation and binding modes (Grumet2003The). These structural features and modifications are critical for L1CAM's function in cell adhesion and signaling.

## Function
L1 cell adhesion molecule (L1CAM) is a critical protein involved in various molecular processes essential for the development and function of the nervous system. It plays a significant role in neuronal migration, axon guidance, and synaptic plasticity. L1CAM facilitates the formation of axon fascicles and promotes neurite outgrowth by interacting with beta-1 integrins, which enhances neuronal migration through the extracellular matrix (Schmid2008L1; cau2022expression). This interaction is mediated by a conserved RGD binding motif in L1CAM, which strengthens cell adhesion to the extracellular matrix (Schmid2008L1).

L1CAM is primarily active in the cell membrane, where it functions as a co-receptor, aiding in intracellular signal transduction and providing the cytoskeletal link necessary for cell and growth cone motility (cau2022expression). It is involved in signaling pathways that include c-Src, PI3 kinase, Rac1 GTPase, and ERK1/2, which enhance cell motility and synaptic targeting (Schmid2008L1). The protein's linkage to the actin cytoskeleton is modulated by ERK, affecting its interaction with ankyrin, which is crucial for cell migration and synaptic targeting (Schmid2008L1).

L1CAM's extracellular localization, often within membrane-bound extracellular vesicles, is crucial for establishing proper cell-cell contacts in neural circuits, influencing axon fasciculation, neuron migration, dendrite morphology, and synaptic plasticity (cau2022expression).

## Clinical Significance
Mutations in the L1CAM gene are responsible for a group of X-linked neurological disorders collectively known as L1 syndrome or CRASH syndrome. These disorders include X-linked hydrocephalus, MASA syndrome, X-linked complicated hereditary spastic paraplegia type 1 (SPG1), and X-linked agenesis of the corpus callosum (ACC) (Vos2010An; Fransen1998Genotypephenotype; Schäfer2010L1CAM). The clinical manifestations of these conditions are highly variable, ranging from severe cases with massive hydrocephalus and early mortality to milder forms with only mild mental retardation (Fransen1998Genotypephenotype; Schäfer2010L1CAM).

Mutations in the L1CAM gene can include missense, nonsense, frameshift, and splice site changes, often affecting the extracellular domain of the L1 protein, which is crucial for cell-cell adhesion in the nervous system (Weller2001Genetic; Yamasaki1997CRASH). These mutations can lead to significant neurological and cognitive impairments, with some mutations causing severe phenotypes due to protein truncation (Ochando2015Prenatal).

Altered expression of L1CAM is also implicated in the progression of human carcinomas, where it enhances cell proliferation, motility, and chemoresistance, making it a potential target for therapeutic interventions in cancer (Schäfer2010L1CAM).

## Interactions
L1CAM (L1 cell adhesion molecule) is involved in various interactions crucial for neural development. It interacts with microtubule-associated protein 1 light-chain 3 (LC3), which is essential for L1-dependent neurite outgrowth and neuronal survival. This interaction occurs via the extracellular LC3-interacting region (LIR) motif in the fourth fibronectin type III domain of L1CAM, and its disruption can lead to reduced neurite outgrowth and neuronal survival (Loers2023Interaction).

L1CAM also binds to ankyrin, a cytoskeletal protein, which inhibits its retrograde movement on the cell surface. This interaction is significant for neuronal growth cone migration and involves a conserved ankyrin-binding motif in L1CAM. Mutations affecting ankyrin binding can alter L1CAM's stationary behavior and retrograde movement, impacting neuronal adhesion and migration (Gil2003Ankyrin).

Additionally, L1CAM interacts with FERM-domain-containing proteins like ezrin, which binds to the neuronal isoform of L1CAM. This interaction is regulated by phosphorylation and is crucial for axon outgrowth during early neuronal development (Herron2009The). L1CAM also engages with nuclear proteins, including splicing factor proline/glutamine-rich (SFPQ) and non-POU domain containing octamer-binding protein (NonO), suggesting roles in transcriptional regulation and DNA repair (Girbes2020The).


## References


[1. (Ochando2015Prenatal) I. Ochando, V. Vidal, J. Gascón, M. Acién, A. Urbano, and J. Rueda. Prenatal diagnosis of x-linked hydrocephalus in a family with a novel mutation inl1camgene. Journal of Obstetrics and Gynaecology, 36(3):403–405, October 2015. URL: http://dx.doi.org/10.3109/01443615.2015.1086982, doi:10.3109/01443615.2015.1086982. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/01443615.2015.1086982)

[2. (Fransen1998Genotypephenotype) E Fransen, G Van Camp, R D’Hooge, L Vits, and P J Willems. Genotype-phenotype correlation in l1 associated diseases. Journal of Medical Genetics, 35(5):399–404, May 1998. URL: http://dx.doi.org/10.1136/jmg.35.5.399, doi:10.1136/jmg.35.5.399. This article has 86 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.35.5.399)

[3. (Vos2010An) Yvonne J. Vos and Robert M.W. Hofstra. An updated and upgradedl1cammutation database. Human Mutation, 31(1):E1102–E1109, January 2010. URL: http://dx.doi.org/10.1002/humu.21172, doi:10.1002/humu.21172. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21172)

[4. (Yamasaki1997CRASH) M. Yamasaki, P. Thompson, and V. Lemmon. Crash syndrome: mutations in l1cam correlate with severity of the disease. Neuropediatrics, 28(03):175–178, June 1997. URL: http://dx.doi.org/10.1055/s-2007-973696, doi:10.1055/s-2007-973696. This article has 139 citations and is from a peer-reviewed journal.](https://doi.org/10.1055/s-2007-973696)

5. (cau2022expression) F Cau, D Fanni, M Manchia, C Gerosa, M Piras, R Murru, P Paribello, T Congiu, P Coni, G Pichiri, and others. Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development. European Review for Medical and Pharmacological Sciences, 26(17):6273–6282, 2022. This article has 3 citations and is from a peer-reviewed journal.

[6. (Girbes2020The) Maria Girbes Minguez, Gerrit Wolters‐Eisfeld, David Lutz, Friedrich Buck, Melitta Schachner, and Ralf Kleene. The cell adhesion molecule l1 interacts with nuclear proteins via its intracellular domain. The FASEB Journal, 34(8):9869–9883, June 2020. URL: http://dx.doi.org/10.1096/fj.201902242R, doi:10.1096/fj.201902242r. This article has 10 citations.](https://doi.org/10.1096/fj.201902242R)

[7. (Gil2003Ankyrin) Orlando D. Gil, Takeshi Sakurai, Ann E. Bradley, Marc Y. Fink, Melanie R. Cassella, James A. Kuo, and Dan P. Felsenfeld. Ankyrin binding mediates l1cam interactions with static components of the cytoskeleton and inhibits retrograde movement of l1cam on the cell surface. The Journal of Cell Biology, 162(4):719–730, August 2003. URL: http://dx.doi.org/10.1083/jcb.200211011, doi:10.1083/jcb.200211011. This article has 78 citations.](https://doi.org/10.1083/jcb.200211011)

[8. (Herron2009The) Lissa R. Herron, Maria Hill, Fleur Davey, and Frank J. Gunn-Moore. The intracellular interactions of the l1 family of cell adhesion molecules. Biochemical Journal, 419(3):519–531, April 2009. URL: http://dx.doi.org/10.1042/bj20082284, doi:10.1042/bj20082284. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20082284)

[9. (Grumet2003The) Martin Grumet. The l1cam extracellular region a multi-domain protein with modular and cooperative binding modes. Frontiers in Bioscience, 8(6):s1210-1225, 2003. URL: http://dx.doi.org/10.2741/1108, doi:10.2741/1108. This article has 105 citations and is from a peer-reviewed journal.](https://doi.org/10.2741/1108)

[10. (Schmid2008L1) Ralf S Schmid and Patricia F Maness. L1 and ncam adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Current Opinion in Neurobiology, 18(3):245–250, June 2008. URL: http://dx.doi.org/10.1016/j.conb.2008.07.015, doi:10.1016/j.conb.2008.07.015. This article has 182 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.conb.2008.07.015)

[11. (Hlavin1991Molecular) Mary Louise Hlavin and Vance Lemmon. Molecular structure and functional testing of human l1cam: an interspecies comparison. Genomics, 11(2):416–423, October 1991. URL: http://dx.doi.org/10.1016/0888-7543(91)90150-d, doi:10.1016/0888-7543(91)90150-d. This article has 113 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/0888-7543(91)90150-d)

[12. (Weller2001Genetic) Sabine Weller and Jutta Gärtner. Genetic and clinical aspects of x-linked hydrocephalus (l1 disease): mutations in thel1camgene: mutations in thel1camgene. Human Mutation, 18(1):1–12, June 2001. URL: http://dx.doi.org/10.1002/humu.1144, doi:10.1002/humu.1144. This article has 152 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.1144)

[13. (Loers2023Interaction) Gabriele Loers, Ralf Kleene, Viviana Granato, Ute Bork, and Melitta Schachner. Interaction of l1cam with lc3 is required for l1-dependent neurite outgrowth and neuronal survival. International Journal of Molecular Sciences, 24(15):12531, August 2023. URL: http://dx.doi.org/10.3390/ijms241512531, doi:10.3390/ijms241512531. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241512531)

[14. (Schäfer2010L1CAM) Michael K. E. Schäfer and Peter Altevogt. L1cam malfunction in the nervous system and human carcinomas. Cellular and Molecular Life Sciences, 67(14):2425–2437, March 2010. URL: http://dx.doi.org/10.1007/s00018-010-0339-1, doi:10.1007/s00018-010-0339-1. This article has 117 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-010-0339-1)